11，Bargman JM.Management of minimal lesion glomerulonephritis:evidence－based recommendations.Kidney Int,1999;55(suppl 70):s3
22，Bugess E.Conservative treatment to slow deterioration of renal function:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s17
33，Burgess E.Management of focal segmental glomerulosclerosis:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s26
44，Jindal kk.Management of idiopathic crescentic and diffuse proliferative glomerulonephritis:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s33
55，Levin A.Mangement of membranoproliferative glomerulonephritis:evidence－based recommendations.Kidney Int,1999;55(suppl 70):s41
66，Muirhead N.Management of idiopathic membranous nephropathy:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s47
77，Nolin L,Courteau M.Management of IgA nephropathy:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s56
88，Maschio and Marcntoni.Angiotensin convertine enzyme inhibitors in nondiabetic renal disease.Curr Opin in Nephrol and Hyperten,1998;7:253
99，Manttari M,Tiula E,AlikoskiT,et al.Effects of hypertension and dyslipdemia on the decline in renal function.Hypertension,1995;26:670
1010，Rayher BL,Byrne MJ.A prospective clinical trial comparing the treatment of idiopathic membranoues nephropathy and nephrotic syndrome with simvastatin and diet,verses diet alone.Clin Nephrol,1996;46:219
3ANDERSON S,RENNKE HG,BRENNER BM. Nigedipine versus fosinopril in uninephrectomized diabetic rats [J]. Kidney Int, 1992,41(4): 891-897.
4CHEN S, CRUZ M,JIM B,et al. Re-versibility of established diabetic glome rulo pathy by anti-TGF-beta antibodies in db/db mice [J]. Biochem Biophys Res Commun, 2003,300( 1 ): 16-22.
5KLAHR S,MORRISSEY JJ. The role of vasoactive compounds, Growth factors and cytokines in the progression of renal disease[J]. Kideney Int,2000,75(Supple) : 7-14.
7Sugiyama H,Kashihara N,Makino H,et al.Apoptosis in glomerularsclerosis[J].Kidney Int,1996;49(1):103-11.
8Zhang W,Khanna P,Chan LL,et al.Diabetes induced apoptosis in rat kidney[J].Biochem Mol Med,1997;61(1):58-62.
9McCubrey JA,Steelman LS,Chappell WH,et al.Roles of the Raf PMEKPERK pathway in cell growth,malignant transformation and drug resistance[J].Biochim Biophys Acta,2007;1773(8):1263-84.
10Anderson S,Rennke HG,Brenner BM.Nifedipine versus fosinopril inuninephrectomized diabetic rats[J].Kidney Int,1992;41(4):891-7.
